Andrew Salzman
Director Técnico/Científico/I+D en HINTO ENERGY, INC. .
Cargos activos de Andrew Salzman
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
HINTO ENERGY, INC. | Director Técnico/Científico/I+D | 07/03/2023 | - |
Radikal Therapeutics, Inc.
Radikal Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Radikal Therapeutics, Inc. develops transformative pharmaceuticals of bifunctional edox-based small molecules. The company was founded by Andrew L. Salzman and is headquartered in West Tisbury, MA. | Presidente | - | - |
Fundador | - | - | |
Salzman Capital Ventures Ltd. | Presidente | - | - |
Respirometics Ltd. | Presidente | - | - |
Salzman Lovelace Investments | Presidente | - | - |
Chilmark Labs, Inc.
Chilmark Labs, Inc. Agricultural Commodities/MillingProcess Industries Chilmark Labs manufactures and produces rare cannabinoids. The company was founded by Andrew Salzman and is headquartered in West Tisbury, MA. | Presidente | - | - |
Fundador | - | - | |
Beetlebung Pharma Ltd.
Beetlebung Pharma Ltd. Pharmaceuticals: OtherHealth Technology Beetlebung Pharma Ltd. focuses on the discovery and development of cannabis-related pharmaceutical therapeutics. The company was founded by Andrew Salzman on March 20, 2018 and is headquartered in Katzrin, Israel. | Presidente | 20/03/2018 | - |
Fundador | 20/03/2018 | - |
Historial de carrera de Andrew Salzman
Antiguos cargos conocidos de Andrew Salzman.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
INNOVATION1 BIOTECH INC. | Director/Miembro de la Junta | 11/08/2022 | 19/10/2022 |
Director Técnico/Científico/I+D | 17/04/2022 | 11/11/2022 | |
CLARITAS PHARMACEUTICALS, INC. | Director/Miembro de la Junta | - | 21/06/2017 |
Director Ejecutivo | - | 21/06/2017 | |
Director Técnico/Científico/I+D | - | 21/06/2017 | |
░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | - | - |
░░░░░░░ | - | - | |
░░░░░░░░░░ ░░░░░░░░ ░░░░░░░ ░░░░░░ ░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░░ | ░░░░░░░░░░ | - |
Formación de Andrew Salzman.
Yale University | Undergraduate Degree |
Harvard Medical School | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 12 |
Israel | 6 |
Operativa
Chairman | 7 |
Founder | 5 |
Director/Board Member | 3 |
Sectorial
Health Technology | 6 |
Consumer Services | 3 |
Commercial Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
HINTO ENERGY, INC. | Energy Minerals |
CLARITAS PHARMACEUTICALS, INC. | Health Technology |
INNOVATION1 BIOTECH INC. | Retail Trade |
Empresas privadas | 11 |
---|---|
Inotek Pharmaceuticals Corp.
Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Inotek Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye. The company's product candidate includes Trabodenoson, an adenosine mimetic that has completed Phase II clinical trials for lowering IOP by restoring the eye's natural pressure control mechanism. It is also developing Trabodenoson plus Latanoprost, a prostaglandin analogue that has completed Phase II clinical trials for use in patients with inadequate responses to treatment with latanoprost; and Trabodenoson monotherapy for the treatment of optic nerve neuropathy. Inotek Pharmaceuticals was founded on July 7, 1999 by Csaba Szabo and Andrew L. Salzman and is headquartered in Lexington, MA. | Health Technology |
Children's Hospital Medical Center of Akron
Children's Hospital Medical Center of Akron Hospital/Nursing ManagementHealth Services Children's Hospital Medical Center of Akron provides health care services. It offers primary care, home care, clinical services, surgical services, and financial services. The company is headquartered in Akron, OH. | Health Services |
Lovelace Respiratory Research Institute
Lovelace Respiratory Research Institute Miscellaneous Commercial ServicesCommercial Services Lovelace Respiratory Research Institute provides biomedical research services. It conducts research and development of countermeasures to chemical, biological, nuclear, radiological, and explosive emerging and environmental threats to human health as well as advancing the diagnosis and treatment of mental illness and other brain disorders. The company was founded in 1947 and is headquartered in Albuquerque, NM. | Commercial Services |
RDD Pharma Ltd.
RDD Pharma Ltd. Medical SpecialtiesHealth Technology RDD Pharma Ltd. develops pharmacological treatments for diseases of the anorectal region. The company was founded by Nir Barak in 2008 and is headquartered in Ramat Hachayal, Israel. | Health Technology |
Radikal Therapeutics, Inc.
Radikal Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Radikal Therapeutics, Inc. develops transformative pharmaceuticals of bifunctional edox-based small molecules. The company was founded by Andrew L. Salzman and is headquartered in West Tisbury, MA. | Commercial Services |
Salzman Capital Ventures Ltd. | |
Respirometics Ltd. | |
Salzman Lovelace Investments | |
Tisbury Pharmaceuticals, Inc.
Tisbury Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Tisbury Pharmaceuticals Ltd. develops and markets groundbreaking therapy to treat primary open angle glaucoma. It focused on the discovery, development, and commercialization of groundbreaking therapy to treat primary open angle glaucoma. The company was founded by Andrew L. Salzman and is headquartered in Beverly, MA. | Health Technology |
Chilmark Labs, Inc.
Chilmark Labs, Inc. Agricultural Commodities/MillingProcess Industries Chilmark Labs manufactures and produces rare cannabinoids. The company was founded by Andrew Salzman and is headquartered in West Tisbury, MA. | Process Industries |
Beetlebung Pharma Ltd.
Beetlebung Pharma Ltd. Pharmaceuticals: OtherHealth Technology Beetlebung Pharma Ltd. focuses on the discovery and development of cannabis-related pharmaceutical therapeutics. The company was founded by Andrew Salzman on March 20, 2018 and is headquartered in Katzrin, Israel. | Health Technology |
- Bolsa de valores
- Insiders
- Andrew Salzman
- Experiencia